What Lowers HbA1c? Evidence-Based Diabetes Interventions

View Evidence Brief

Evidence on improving hba1c reduction

Evidence related to lowering or improving HbA1c/A1C in diabetes management.

Build your Evidence Workspace

Save evidence about the topics you care about.

223

Studies

100

Evidence Pairs

Extensive Research

Evidence Base: 71/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

HbA1c Reduction evidence appears to center on Tirzepatide.

Among 223 indexed studies and 98 interventions, the strongest signals are summarized from the available evidence. Tirzepatide appears to be one of the clearer current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: June 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Tirzepatide appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 6 evidence pairs - 38 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsGenerally consistent

Tirzepatide

12 studies

EvidenceScore™

84/100

ConsistencyScore™

100/100

Remote multiprofessional educational program

5 studies

EvidenceScore™

83/100

ConsistencyScore™

100/100

Evidence Snapshot

223

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Evidence freshness

Jun 2026

Latest indexed

Key Findings

Key patterns and insights identified across the research landscape

Strong positive signal

Semaglutide shows strong evidence for improving HbA1c

Semaglutide → HbA1c

Across 11 studies, Semaglutide shows a consistent strong positive signal for HbA1c.

11 studies

EvidenceScore™: 86.53846153846153/100

View supporting studies

Evidence signal

Usual care shows evidence for HbA1c

Usual care → HbA1c

Across 9 studies, Usual care shows a consistent evidence signal for HbA1c.

9 studies

EvidenceScore™: 85.66666666666666/100

View supporting studies

Moderate positive signal

Metformin may improve HbA1c

Metformin → HbA1c

Across 11 studies, Metformin shows a moderate positive signal for HbA1c.

11 studies

EvidenceScore™: 85.20979020979021/100

View supporting studies

Strong positive signal

Tirzepatide shows strong evidence for improving HbA1c

Tirzepatide → HbA1c

Across 12 studies, Tirzepatide shows a consistent strong positive signal for HbA1c.

12 studies

EvidenceScore™: 83.89102564102565/100

View supporting studies

Moderate positive signal

DSMES may improve HbA1c

DSMES → HbA1c

Across 7 studies, DSMES shows a moderate positive signal for HbA1c.

7 studies

EvidenceScore™: 83.83516483516483/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Metformin is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Metformin

Semaglutide

Metformin

11 studies

EvidenceScore™

85/100

ConsistencyScore™

55/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present

Evidence basis: 5 evidence pairs - 46 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Calorie restriction may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Calorie restriction

Dipeptidyl peptidase-4 inhibitors

Calorie restriction

4 studies

EvidenceScore™

79/100

ConsistencyScore™

73/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 5 evidence pairs - 17 studies

View supporting studies

Question Highlights

Quick answers to the most important questions supported by the available evidence.

Explore all evidence questions

What improves hba1c reduction?

Semaglutide, Usual care, and Metformin are among the most studied approaches for HbA1c Reduction.

Semaglutide, Usual care, and Metformin are among the best-supported options in the available evidence across 223 studies.

View full answer

Does Semaglutide improve hba1c reduction?

Semaglutide appears to improve HbA1c.

Strong evidence is based on 11 supporting studies.

Population details are unavailable.

View full answer

Semaglutide vs Usual care for hba1c reduction?

Semaglutide and Usual care have available evidence for HbA1c Reduction, but the comparison requires review of the underlying studies.

Evidence is available for both Semaglutide and Usual care; the underlying studies are needed for a direct comparison.

Population details are unavailable.

View full answer

Explore all evidence questions

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Questions Answered by the Evidence

What improves hba1c reduction?

outcome achievement

Emerging Evidence

Semaglutide, Usual care, and Metformin are among the most studied approaches for HbA1c Reduction.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 86.5 | strong positive | ConsistencyScore™ Consistent | 11 studies
2
Usual care
EvidenceScore™ Strong | EvidenceScore™ 85.7 | weak positive | ConsistencyScore™ Consistent | 9 studies
3
Metformin
EvidenceScore™ Strong | EvidenceScore™ 85.2 | moderate positive | ConsistencyScore™ Generally Consistent | 11 studies

Why this answer: This answer is based on 223 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 6 of 223 supporting studies. Reported populations varied; examples included Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between... and Participants were adults with type 2 diabetes and high cardiovascular risk recruited from a Shanghai tertiary hospital. Groups were generally balanced at baseline, although hypertension and some background medication....

Does Semaglutide improve hba1c reduction?

intervention effectiveness

Strong Evidence

Semaglutide appears to improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 86.5 | strong positive | ConsistencyScore™ Consistent | 11 studies

Why this answer: This answer is based on 11 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Usual care improve hba1c reduction?

intervention effectiveness

Strong Evidence

Usual care may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Usual care
EvidenceScore™ Strong | EvidenceScore™ 85.7 | weak positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Metformin improve hba1c reduction?

intervention effectiveness

Strong Evidence

Metformin may improve HbA1c.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
Metformin
EvidenceScore™ Strong | EvidenceScore™ 85.2 | moderate positive | ConsistencyScore™ Generally Consistent | 11 studies

Why this answer: This answer is based on 11 supporting studies with generally consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Semaglutide vs Usual care for hba1c reduction?

compare

Strong Evidence

Semaglutide and Usual care have available evidence for HbA1c Reduction, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 86.5 | strong positive | ConsistencyScore™ Consistent | 11 studies
2
Usual care
EvidenceScore™ Strong | EvidenceScore™ 85.7 | weak positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 20 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

How can I lower hba1c?

sub outcome

Emerging Evidence

Semaglutide, Usual care, and Metformin are among the most studied approaches for HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 86.5 | strong positive | ConsistencyScore™ Consistent | 11 studies
2
Usual care
EvidenceScore™ Strong | EvidenceScore™ 85.7 | weak positive | ConsistencyScore™ Consistent | 9 studies
3
Metformin
EvidenceScore™ Strong | EvidenceScore™ 85.2 | moderate positive | ConsistencyScore™ Generally Consistent | 11 studies

Why this answer: This answer is based on 223 supporting studies with consistent results and a positive effect signal.

Applicability

What has the strongest evidence for hba1c reduction?

evidence strength

Strong Evidence

Semaglutide, Usual care, and Metformin have the strongest available evidence signals in this evidence set.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 86.5 | strong positive | ConsistencyScore™ Consistent | 11 studies
2
Usual care
EvidenceScore™ Strong | EvidenceScore™ 85.7 | weak positive | ConsistencyScore™ Consistent | 9 studies
3
Metformin
EvidenceScore™ Strong | EvidenceScore™ 85.2 | moderate positive | ConsistencyScore™ Generally Consistent | 11 studies

Why this answer: This answer is based on 48 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 48 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

Evidence summary for AI and search

Among 223 indexed studies and 98 interventions, the strongest signals are summarized from the available evidence. Tirzepatide appears to be one of the clearer current evidence signals.